Bixiye
P16-21 Genetic/Molecular Lab Test Coding Reimbursement Policy for MHCP
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2021
Natiijooyinka Raadinta
Soo bandhiga 1731 - 1740 ee natiijooyinka 4229
Bixiye
2021 April Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2021
Bixiye
P17-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2021
Bixiye
P15-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates — Effective May 31, 2021
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2021
Bixiye
QP22-21 Commercial and MHCP Pharmacy Benefit Exclusion for Nulibry™
Taariikhda uu dhaqangalayo Barnaamijka: Mar 24, 2021
Bixiye
QP23-21 Cellular and Gene Therapy Product Reimbursement Policy Update
Taariikhda uu dhaqangalayo Barnaamijka: Mar 24, 2021